Treatt PLC in brief
Treatt PLC is a listed company in the Chemicals industry, based in the UK. It was founded in 1886. Its last known market value was $390 M (January 2024); there is no current figure. In the year to September 2025 it had sales of $174 M and a net profit of $7 M, about 4 cents of profit for every dollar of sales. Its shares trade under the symbol 5TT.F (Frankfurt).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Treatt PLC
Treatt is a trusted natural extracts and ingredients manufacturer company to the global beverage, flavour, fragrance and consumer goods markets from bases in the UK, the US and China. The company annual revenue is 124 million GBP and annual net income is 15 million GBP for year ending September 2021. The headquarters is in UK.
Treatt PLC timeline
- 1886
- 🏁· approximateFounded
- 2014
- •Legal Entity Identifier issuedLEI 213800G4OJM9F7G9LG39 registered.
Events of Treatt PLC from the company record and the GLEIF LEI register. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in UK: #380 (Jan 2020) · #470 (Jan 2021) · #450 (Jan 2022) · #473 (Dec 2022) · #456 (Jul 2023) · #496 (Jan 2024)
Key ratios
- P/E ratio
- —
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- —
- Net margin
- 3.8%
- Operating margin
- 5.6%
- Return on equity
- 3.7%
- Liabilities / assets
- 20.1%
- Revenue growth
- -9.1%
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Sep 2025 | $174M | -9.1% | $10M | $7M | 3.8% |
| Sep 2024 | $192M | — | $24M | $18M | 9.2% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Sep 2025 | $15M | $6M | $9M | — | — |
| Sep 2024 | $27M | $7M | $20M | — | — |
Annual results
- Revenue
- $174 M
- Operating income
- $10 M
- Net income
- $7 M
For year ending September-2025 · source: official annual report (ESEF)
Balance sheet
- Total assets
- $227 M
- Total liabilities
- $46 M
- Total equity
- $181 M
As of September-2025
Mutual funds holding Treatt PLC#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Avantis International Small Cap Value ETFAmerican Century ETF Trust | 273,714 | $1 M | — | <0.01% | +4.9% | May 31, 2026 |
| 🇺🇸 The Gabelli Small Cap Growth FundGabelli Funds, LLC | 120,000 | $0 M | — | 0.03% | no change | Jun 30, 2026 |
| 🇺🇸 TETON Westwood Mighty Mites FundTeton Advisors, LLC | 98,285 | $0 M | — | 0.19% | no change | Jun 30, 2026 |
| 🇺🇸 Avantis International Equity ETFAmerican Century ETF Trust | 85,943 | $0 M | — | <0.01% | +13% | May 31, 2026 |
| 🇺🇸 State Street SPDR S&P International Small Cap ETFSSGA Funds Management, Inc. | 23,419 | $0 M | — | 0.01% | +1.0% | Jun 30, 2026 |
| 🇺🇸 Gabelli Dividend & Income TrustGabelli Funds, LLC | 15,000 | $0 M | — | <0.01% | −40% | Jun 30, 2026 |
| 🇺🇸 Gabelli Equity Trust IncGabelli Funds, LLC | 15,000 | $0 M | — | <0.01% | −40% | Jun 30, 2026 |
| 🇺🇸 Gabelli Global Small & Mid Cap Value TrustGabelli Funds, LLC | 12,700 | $0 M | — | 0.04% | no change | Jun 30, 2026 |
| 🇺🇸 Avantis International Equity FundAmerican Century ETF Trust | 5,081 | $0 M | — | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Avantis International Small Cap Equity ETFAmerican Century ETF Trust | 4,032 | $0 M | — | <0.01% | +19% | May 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 10 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Ownership and subsidiaries
- R.C.TREATT & CO.LIMITED🇬🇧 BURY ST EDMUNDS
- TREATT USA, INC.🇺🇸 TALLAHASSEE
Treatt PLC scorecard#
Passes 2 of the 4 checks that could be worked out. Fiscal year 2025.
Valuationnot known
- –P/E below its peers' medianNo market cap.
- –Price to book below its peers' medianNo market cap.
- –Price to sales below its peers' medianNo market cap.
- –Free cash flow yield above 5%No market cap.
- –Earnings yield above the 10-year Treasury yieldNo market cap.
- –The price assumes slower growth than the last three years'No market cap.
Growth0 of 1
- ✗Revenue grew in the newest year-9.1%Revenue down 9.1% in fiscal 2025.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- –Earnings per share grew in the newest yearEarnings per share of two years are not on file.
- –Net income higher than five years earlierNet income of five years earlier is not on file.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability2 of 3
- ✓Profitable in the newest year$7 MNet income $7 M in fiscal 2025.
- –Profitable in each of the last five yearsFive years of net income are not on file.
- ✓Operating margin above its peers' median5.5%5.5% against Chemicals's median of 4.4% (73 companies).
- ✗Return on equity above 15%3.7%3.7% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial healthnot known
- –Short-term assets cover short-term liabilitiesCurrent assets and liabilities are not on file.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- –Cash from operations positive in each of the last three yearsThree years of operating cash flow are not on file.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returnsnot known
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- –Share count up no more than 2% in a yearShare counts of two years are not on file.
- –Dividends and buybacks above 3% of the market valueNo market cap.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (esef), the medians of Chemicals, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Treatt PLC's statements, beside the median of Chemicals.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | 5.6% | 4.4% | |
| Net margin | 3.8% | 2.1% | |
| Return on equity | 3.7% | 1.9% | |
| Revenue growth | -9.1% | -0.8% | |
| Free cash flow margin | 5.0% | 3.6% |
3of 6on the Piotroski tests of financial strength
- Revenue fell 9.1% against the year before.
Treatt PLC: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in GBP millions; per-share figures in GBP; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Sep 30, 2025 | FY 2024to Sep 30, 2024 | FY 2023to Sep 30, 2023 | FY 2022to Sep 30, 2022 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 132−11.8%100% | 150+1.9%100% | 147+5.1%100% | 140—100% | |
| Cost of revenue | 98−7.6%74.1% | 106+3.6%70.7% | 103+1.5%69.6% | 101—72.1% | |
| Gross profit | 34−22.0%25.9% | 44−2.0%29.3% | 45+14.7%30.4% | 39—27.9% | |
| General and administrative | 25−1.6%18.5% | 25−14.4%16.6% | 29+21.9%19.8% | 24—17.1% | |
| Operating income | 7.4−60.6%5.6% | 19+28.7%12.4% | 15−13.0%9.9% | 17—11.9% | |
| Interest and finance income | 0.3+26.6%0.2% | 0.2+104%0.2% | 0.1+1300%0.1% | 0.0—0.0% | |
| Interest expense and finance costs | 0.6−35.9%0.5% | 1.0−7.7%0.7% | 1.1+107%0.7% | 0.5—0.4% | |
| Income before tax | 7.0−60.9%5.3% | 18+32.3%11.9% | 14−16.3%9.2% | 16—11.5% | |
| Income tax | −1.9—−1.5% | −4.1−256%−2.7% | 2.6−9.1%1.8% | 2.9—2.0% | |
| Net income including minority interests | 5.1−63.5%3.8% | 14+26.6%9.2% | 11−17.8%7.4% | 13—9.5% | |
| Balance sheet | |||||
| Cash and cash equivalents | 1.7−2.3%1.0% | 1.8+121%1.1% | 0.8—0.5% | −3.8—−2.0% | |
| Receivables | 26−20.6%15.6% | 33+0.4%19.6% | 33−11.2%18.8% | 37—19.7% | |
| Inventory | 63+13.9%37.1% | 55−12.0%32.5% | 62−8.7%35.7% | 68—36.3% | |
| Current assets | 91+0.9%54.2% | 91−6.1%53.6% | 96−11.1%55.1% | 109—57.7% | |
| Property, plant and equipment | 70+0.3%41.5% | 70−2.4%41.3% | 72−3.7%40.9% | 74—39.5% | |
| Right-of-use (leased) assets | 0.9+133%0.5% | 0.4−29.6%0.2% | 0.5+43.5%0.3% | 0.4—0.2% | |
| Other intangible assets | 2.2−12.0%1.3% | 2.5−7.9%1.5% | 2.8−14.2%1.6% | 3.2—1.7% | |
| Non-current assets | 77−1.4%45.8% | 78−0.3%46.4% | 79−1.4%44.9% | 80—42.3% | |
| Total assets | 169−0.2%100% | 169−3.5%100% | 175−7.0%100% | 188—100% | |
| Accounts payable | 22+16.7%12.9% | 19−9.7%11.1% | 21−9.6%11.8% | 23—12.2% | |
| Current liabilities | 29+28.4%17.2% | 23−30.7%13.4% | 33−29.7%18.6% | 46—24.6% | |
| Lease liabilities (non-current) | 0.7+229%0.4% | 0.2−41.3%0.1% | 0.4+28.2%0.2% | 0.3—0.2% | |
| Non-current liabilities | 4.9−7.3%2.9% | 5.3+0.8%3.1% | 5.2−34.7%3.0% | 8.0—4.3% | |
| Total liabilities | 34+21.6%20.1% | 28−26.3%16.5% | 38−30.5%21.6% | 54—28.9% | |
| Retained earnings | 109−5.1%64.8% | 115+9.6%68.2% | 105+9.4%60.1% | 96—51.1% | |
| Total equity | 135−4.5%79.9% | 141+2.8%83.5% | 137+2.5%78.4% | 134—71.1% | |
| Cash-flow statement | |||||
| Share-based compensation | 0.3−43.0%0.2% | 0.5−58.1%0.3% | 1.2+17.6%0.8% | 1.0—0.7% | |
| Cash from operating activities | 11−46.4%8.5% | 21−2.0%14.0% | 21—14.6% | −1.4—−1.0% | |
| Capital expenditure | −4.7—−3.6% | −5.4—−3.6% | −5.5—−3.7% | −12—−8.5% | |
| Intangible assets bought | −0.2—−0.2% | −0.2—−0.2% | −0.2—−0.1% | −0.9—−0.7% | |
| Cash from investing activities | 5.0−11.7%3.8% | 5.6—3.7% | −4.2—−2.8% | −7.2—−5.1% | |
| Debt issued | 4.6+195%3.5% | 1.6−85.4%1.0% | 11+13.1%7.2% | 9.4—6.7% | |
| Debt repaid | 0—0.0% | −10.0—−6.6% | −18—−12.0% | −0.4—−0.3% | |
| Shares issued | 0.0−50.0%0.0% | 0.0−66.7%0.0% | 0.0−33.3%0.0% | 0.0—0.0% | |
| Dividends paid | −5.1—−3.9% | −4.9—−3.3% | −4.8—−3.3% | −4.8—−3.4% | |
| Cash from financing activities | 6.3−56.1%4.8% | 14—9.6% | −13−386%−8.5% | 4.4—3.1% | |
| Exchange-rate effect on cash | 0.1−32.0%0.0% | 0.1—0.1% | −0.2−278%−0.1% | 0.1—0.1% | |
| Change in cash | 0.0−95.8%0.0% | 1.0−78.9%0.7% | 4.6—3.1% | −4.1—−2.9% | |
| Report | ESEF | ESEF | ESEF | ESEF | |
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: ESEF annual reports (filings.xbrl.org) · as of Sep 30, 2025. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Where Treatt PLC operates: 2 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 2 subsidiaries on file.
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
How Treatt PLC compares in Chemicals
- Revenue$174 M · higher than 13% of 421
- Net margin3.8% · higher than 30% of 409
- Revenue growth-9.1% · higher than 22% of 111
- 🇯🇵 JCU Corporation$870 M
- 🇨🇳 Grace Fabric Technology Co., Ltd.$20.7 B
- 🇺🇸 TeraWulf Inc.$6.7 B
- 🇩🇪 Nabaltec AG$134 M
- 🇨🇳 Novoray Corporation$5.9 B
- 🇺🇸 Gevo, Inc.$299 M
Peer comparison · Chemicals
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Treatt PLC🇬🇧 | $390 M | — | 3.8% | -9.1% |
| Linde plc🇬🇧 | $231.0 B | 33.0× | 19.3% | +3.0% |
| Air Liquide🇫🇷 | $124.8 B | 29.9× | 13.1% | +3.8% |
| The Sherwin-Williams Company🇺🇸 | $81.4 B | 30.4× | 10.7% | +2.1% |
| Ecolab Inc.🇺🇸 | $79.7 B | 38.3× | 12.0% | +2.2% |
| Shin-Etsu Chemical Co., Ltd.🇯🇵 | $74.3 B | 23.1× | 18.4% | — |
| Air Products and Chemicals, Inc.🇺🇸 | $66.5 B | — | -0.4% | -0.5% |
| Nan Ya Plastics Corporation🇹🇼 | $55.1 B | 372.9× | 1.7% | — |
| BASF SE🇩🇪 | $52.7 B | 27.4× | 2.7% | -18.8% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Linde plc$231.0 B
- Air Liquide$124.8 B
- The Sherwin-Williams Company$81.4 B
- Ecolab Inc.$79.7 B
- Shin-Etsu Chemical Co., Ltd.$74.3 B
- Air Products and Chemicals, Inc.$66.5 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Annual results:
- For year ending September-2025
- Balance sheet:
- As of September-2025
- Profile updated:
- Nov 4, 2026
Figures from Official annual report (ESEF), value.today research, GLEIF register.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Treatt PLC? Verify and update this profile — free
Show Treatt PLC's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.